Lecia V. Sequist

Lecia V. Sequist on Side Effects From Agents for Resistant Lung Cancer

September 25, 2015

Article

Lecia V. Sequist, discusses the adverse event profiles of rociletinib (CO-1686) and osimertinib (AZD9291).

Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLC

September 24, 2015

Article

Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.